Papers: 10.1371/journal.pone.0053297

https://doi.org/10.1371/journal.pone.0053297

Impact of Natalizumab on Ambulatory Improvement in Secondary Progressive and Disabled Relapsing-Remitting Multiple Sclerosis

Cited by: 35
Author(s): Diego Cadavid, Stéphanie Jurgensen, Sophia Lee
Published: over 12 years ago

Software Mentions 1